Drugs / Jardiance
Jardiance cost
empagliflozin · Boehringer Ingelheim. Every official price for Jardiance, side by side, with who pays it.
Short answer
We found no list price published by Boehringer Ingelheim. Medicare's negotiated price, in effect since January 1, 2026, is $197 for a 30-day supply. Pharmacies paid an average of $11.19 per tablet (NADAC, Oct 21, 2026). In Medicare Part D, the yearly out-of-pocket limit is $2,100 in 2026 and $2,400 in 2027.1234
Source: CMS, data.medicaid.gov (NADAC) and Medicare.gov · checked Oct 23, 2026
Every official price
| Price | Amount | What it is | Date |
|---|---|---|---|
| Maker's list price (WAC) | Not published | We found no current list price on Boehringer Ingelheim's own pages, so we do not show one. | — |
| Medicare negotiated price | $1971 | For a 30-day supply, under Medicare's drug price negotiation, for Part D. The drug company must make it available to pharmacies that fill it for people with Medicare.6 | From Jan 1, 2026 |
| List price CMS compared it with | $5731 | The 2023 list price for a 30-day supply, in CMS's table. | 2023 |
| Pharmacy acquisition cost (NADAC) Jardiance 10 mg tablet | $11.192 | Per tablet. The national average price pharmacies pay to buy it. | Oct 21, 2026 |
| Pharmacy acquisition cost (NADAC) Jardiance 25 mg tablet | $11.192 | Per tablet. The national average price pharmacies pay to buy it. | Oct 21, 2026 |
These are prices the drug company, Medicare and pharmacies use. What you pay depends on your coverage; see below.
With Medicare
- When filled at a pharmacy under a Part D plan, Part D's yearly out-of-pocket limit is $2,100 in 20263 and $2,400 in 2027.4 The standard Part D deductible is $700 in 2027.5 Your plan's own deductible and copays can be lower.
- Higher income? Part B and Part D premiums can include IRMAA: IRMAA brackets.
With commercial insurance or no insurance
- What you pay depends on your plan's copay or coinsurance. The maker lists its savings and support options here: Boehringer Ingelheim: Jardiance savings and support. We link to it but do not copy its terms.
Which drug, which dose, and whether to start, stop or switch are medical decisions. Ask your doctor or pharmacist.
Get an email when a price or rule changes
Only when an official GLP-1 self-pay price or a Medicare or Medicaid rule changes, at most once a week, with the official source for every change.
Official sources for this page (6)
“Jardiance Boehringer Ingelheim Diabetes; Heart failure; Chronic kidney disease $197.00 $573.00 66%”
- data.medicaid.gov: NADAC (National Average Drug Acquisition Cost) 2026 · as of Oct 23, 2026
“Out-of-pocket limit Yearly $2,100 (in 2026).”
Medicare.gov: Medicare costs · as of Oct 23, 2026“Out-of-Pocket Threshold: $2,100 Out-of-Pocket Threshold: $2,400”
CMS: CY 2027 Medicare Advantage and Part D Rate Announcement (Table V-6) · as of Oct 23, 2026“Deductible: $615 Deductible: $700”
CMS: CY 2027 Medicare Advantage and Part D Rate Announcement (Table V-6) · as of Oct 23, 2026“A participating drug company with a selected drug is required to ensure the negotiated price is made available to eligible individuals and to the pharmacies, mail-order services, and other entities that dispense the selected drug to such individuals.”